Patient Profile-Based Management with Nintedanib in Patients with Idiopathic Pulmonary Fibrosis

Patient Profile-Based Management with Nintedanib in Patients with Idiopathic Pulmonary Fibrosis

Abstract A severe and progressive interstitial lung disease (ILD) known as idiopathic pulmonary fibrosis (IPF) has an unknown etiology with poorly defined mechanisms of development. Among the currently prescribed pharmacological interventions for IPF, nintedanib demonstrates the ability to decelerat...

Full description

Saved in:
Bibliographic Details
Main Authors: Vinod K. Viswanathan, Aloke G. Ghoshal, Anant Mohan, Ketaki Patil, Chaitanya Bhargave, Sanjay Choudhari, Suyog Mehta
Format: Article
Language:English
Published: Adis, Springer Healthcare 2024-09-01
Series:Pulmonary Therapy
Subjects:
Adverse effects
Antifibrotic
Forced vital capacity
Gastrointestinal
Idiopathic pulmonary fibrosis
Nintedanib
Online Access:https://doi.org/10.1007/s41030-024-00271-1
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1007/s41030-024-00271-1

Similar Items